SCHEMBL11636342

SCHEMBL11636342

CC(=O)Oc1cccc2c1O[C@@H](c1ccccc1)CC2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.50
KDM4E B2RXH2 3/20 0.50
AR P10275 3/20 0.50
SLC22A12 Q96S37 3/20 0.50
MAOB P27338 3/20 0.50
HSD17B10 Q99714 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
MAPT P10636 3/20 0.49
GAA P10253 2/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49
PABPC1 P11940 1/20 0.49
APEX1 P27695 1/20 0.49
RECQL P46063 1/20 0.49
KMT2A Q03164 1/20 0.49
EIF4H Q15056 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PTPN1 P18031 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2399205 0.91 SLC22A12 (0.50) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL7604105 0.86 CYP19A1 (0.49) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL1242979 0.84 KDM4E (0.65) CYP19A1KDM4EARMAOBHSD17B10
SCHEMBL10361402 0.77 MAOB (0.54) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL11050274 0.77 PTPN1 (0.51) CYP19A1ARMAOBMAPTPTPN1
SCHEMBL130267 0.76 CYP19A1 (0.59) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL9205670 0.76 CYP19A1 (0.59) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL4163503 0.74 CYP19A1 (0.60) CYP19A1KDM4EARMAOBHSD17B10
SCHEMBL6703206 0.74 MAOB (0.59) CYP19A1KDM4EARSLC22A12MAOB
SCHEMBL10360963 0.74 MAOB (0.59) CYP19A1KDM4EARSLC22A12MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4105675-A REDUCING ACYLATED FLAVANONE WITH ALKALI BOROHYDRIDE TO REMOVE OXYGEN FUNCTION AT 4-POSITION; OXIDIZING WITH HALOGENATED BENZOQUINONE TO FORM SALT THE COCA-COLA COMPANY (US) 1978-08-08 US disclosed